ADPT Stock | | | USD 6.38 0.33 4.92% |
Adaptive Biotechnologies financial indicator trend analysis is way more than just evaluating Adaptive Biotechnologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adaptive Biotechnologies is a good investment. Please check the relationship between Adaptive Biotechnologies Current Deferred Revenue and its Total Current Liabilities accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
Current Deferred Revenue vs Total Current Liabilities
Current Deferred Revenue vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Adaptive Biotechnologies Current Deferred Revenue account and
Total Current Liabilities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Adaptive Biotechnologies' Current Deferred Revenue and Total Current Liabilities is 0.98. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Adaptive Biotechnologies Corp, assuming nothing else is changed. The correlation between historical values of Adaptive Biotechnologies' Current Deferred Revenue and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Adaptive Biotechnologies Corp are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Current Deferred Revenue i.e., Adaptive Biotechnologies' Current Deferred Revenue and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Total Current Liabilities
Total Current Liabilities is an item on Adaptive Biotechnologies balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Adaptive Biotechnologies Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Adaptive Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adaptive Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
Selling General Administrative is likely to drop to about 57.1
M in 2024.
Sales General And Administrative To Revenue is likely to drop to 0.35 in 2024
Adaptive Biotechnologies fundamental ratios Correlations
Click cells to compare fundamentals
Adaptive Biotechnologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Adaptive Biotechnologies fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to
measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to
predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.